ODI Pharma AB (publ) (FRA:6OD)
Germany
· Delayed Price · Currency is EUR 0.1050
-0.0150 (-12.50%)
At close: Dec 4, 2025
ODI Pharma AB Revenue
ODI Pharma AB had revenue of 5.97M SEK in the quarter ending September 30, 2025, with 4,050.37% growth. This brings the company's revenue in the last twelve months to 8.96M, down -59.10% year-over-year. In the fiscal year ending June 30, 2025, ODI Pharma AB had annual revenue of 3.13M, down -85.94%.
Revenue (ttm)
8.96M SEK
Revenue Growth
-59.10%
P/S Ratio
3.49
Revenue / Employee
8.96M SEK
Employees
1
Market Cap
2.83M EUR
Revenue Chart
* This company reports financials in SEK.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SAP SE | 36.49B |
| Siemens Aktiengesellschaft | 78.91B |
| Allianz SE | 105.02B |
| Deutsche Telekom AG | 121.02B |
| Siemens Energy AG | 39.08B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 62.10B |
| Rheinmetall AG | 11.00B |
| Deutsche Bank Aktiengesellschaft | 29.86B |